We examined the extent to which studies aimed at testing interventions to improve antiretroviral adherence have targeted the facilitators of and barriers known to affect adherence. Of the 88 reports reviewed, 41 were reports of descriptive studies conducted with US HIV-positive women and 47 were reports of intervention studies conducted with US HIV-positive persons. We extracted from the descriptive studies all findings addressing any factor linked to antiretroviral adherence and from the intervention studies, information on the nature of the intervention, the adherence problem targeted, the persons targeted for the intervention, and the intervention outcomes desired. We discerned congruence between the prominence of substance abuse as a factor identified in the descriptive studies as a barrier to adherence and its prominence as the problem most addressed in those reports of intervention studies that specified the problems targeted for intervention. We also discerned congruence between the prominence of family and provider support as factors identified in the descriptive studies as facilitators of adherence and the presence of social support as an intervention component and outcome variable. Less discernible in the reports of intervention studies was specific attention to other factors prominent in the descriptive studies, which may be due to the complex nature of the problem, individualistic and rationalist slant of interventions, or simply the ways interventions were presented. Our review raises issues about niche standardization and intervention tailoring, targeting, and fidelity.
Reviews of descriptive studies have shown many and varied factors influencing antiretroviral adherence (e.g. Ammassari et al., 2002; Mills et al., 2006; Vervoort, Borleffs, Hoepelman, & Grypdonck, 2007) . Reviews of intervention studies indicate that the active component has yet to be identified that will produce consistently desirable adherence rates (e.g. Rivet Amico, Harman, & Johnson, 2006; Rueda et al., 2006; Simoni, Pearson, Pantalone, Marks, & Crepaz, 2006) . The use of diverse measurements of adherence (Liu et al., 2001; Mannheimer et al., 2008; Paterson, Potoski, & Capitano, 2002) , and recent findings that the levels of adherence required to achieve viral suppression and prevent drug resistance may vary with drug regimen (e.g. Bangsberg et al., 2006) , complicate efforts to understand and improve adherence.
Intervention studies ought to be firmly grounded in empirically based understandings of the problems to be targeted (Sidani & Braden, 1998) . However, the congruence between factors identified through empirical studies to influence adherence and the targets of interventions designed to enhance adherence has not yet been explored. The purpose of the systematic review reported here was to ascertain the extent to which a set of antiretroviral adherence intervention studies targeted the facilitators of and barriers to adherence identified in a set of antiretroviral adherence descriptive studies.
Method
This systematic review was conducted in the course of a research project aimed at developing methods to synthesize qualitative and quantitative research findings. Search and retrieval procedures were thus, selected to accommodate methodological objectives, not to answer research questions about antiretroviral adherence per se. The goal was to obtain a welldefined but manageable sample of research reports with sufficient methodological diversity (i.e. different types of qualitative and quantitative studies) and topical uniformity (all on antiretroviral adherence) to permit the intensive analysis and experimentation with technique required in a study of methods. Specifically, we confined our search to published reports as unpublished reports contained no methodological variation not found in published reports.
We confined our search to studies conducted in the USA as national differences in healthcare delivery and attitudes toward HIV infection would have added a level of complexity to analysis that would not advance the methodological aims of our study. We confined our search for descriptive studies to those conducted with women only. Reviews of studies conducted with men and women or men only (e.g. those cited above) indicate no factor influencing adherence not also found in women-only studies. Yet, additional factors are found in women-only studies (e.g. those related to reproduction and mothering); indeed, women's unique circumstances are often cited in reports of women-only studies as justifications for studying women only. Men-only descriptive studies can, thus, be considered a subset of women-only descriptive studies. Antiretroviral intervention studies conducted with women and men can be assumed to address factors common to both. All of these sampling delimitations constitute limitations to the review presented here, yet all systematic reviews entail such limitations (Sandelowski, Voils, & Barroso, 2007) .
Forty-one reports of antiretroviral adherence descriptive (14 qualitative and 27 quantitative observational) studies were retrieved between June 2005 and October 2007. (See entries with a superscript 'd' in the reference list.) Forty-seven reports of antiretroviral intervention studies were retrieved in October 2007. We used electronic databases housing citations to literature across the health, behavioral, and social sciences, including Academic Search Elite, Alternative Press Index, Cochrane Central Register of Controlled Trials, Cumulative Index to Nursing and Allied Health Literature (CINAHL), PsycINFO, PubMed, and Sociological Abstracts. We used variations (e.g. extensions, truncations, synonyms) of the following search terms to accommodate the distinctive features of each of these databases: HIV, AIDS, antiretroviral, adherence, compliance, clinical trial, intervention, and experiment. We augmented electronic searching with the use of ancestry and descendency approaches (Cooper, 1998) , in addition to hand-searching the print collections of our university libraries for books, anthologies, and other documents on HIV/AIDS likely to include relevant reports.
Antiretroviral descriptive studies
Reports of descriptive studies were eligible for inclusion if they were of empirical qualitative and quantitative observational studies of adherence to antiretroviral therapy conducted with HIV-positive women of any race/ethnicity, class, or nationality living in the USA, and published in or after 1997 (when protease inhibitors became part of the standard of care) to the present (2007) . We accepted reports of studies conducted with HIV-positive women that included HIV-positive men if an explicit research purpose was to compare women and men in relation to antiretroviral adherence and if the report contained findings focused on women.
We extracted from the qualitative studies all findings addressing any aspect of antiretroviral adherence and calculated their frequency effect sizes, or the number of reports containing a finding divided by the total number of reports (Sandelowski & Barroso, 2007) . We extracted from the quantitative observational studies all relationships addressing adherence and another variable, and computed their effect sizes. The effect size index that we used is Cohen's d (Cohen, 1988) , which is the standardized difference between two means (in these studies, the difference in mean adherence between two groups, such as drug users versus non-users). Calculating d enables comparisons to be made across studies because all differences in means are on the same scale. A value of 0 indicates no difference between means. Cohen suggested that values of 0.20, 0.50, and 0.80 represent small, medium, and large differences, respectively. Because we would not expect interventions to address factors that have not been shown to be related to adherence, we excluded findings that did not meet the criterion for a ''small'' effect size (i.e. any d B0.20) in quantitative research. We used effect sizes instead of p-values, which are influenced by sample size to a greater degree (Rosenthal, 1984) . We also excluded findings for which there was insufficient information for calculating an effect size even after contacting the authors. Whenever only bivariate or only multivariable findings were addressed in a report, we retained those findings, but in reports in which the same variable was addressed in both bivariate and multivariable analyses, we used the bivariate relationship. This is because an effect size for a partial relationship may be greater or lesser, depending on which variables are chosen to be included in the multivariable model. Multivariable findings, therefore, are less comparable than bivariate findings because they estimate different partial relationships (Voils, Barroso, Hasselblad, & Sandelowski, 2007) .
We then grouped these findings into categories and the findings within these categories into factors favoring adherence and non-adherence. (Tables showing the results of these data extractions and computations are available from the first author on request.)
Antiretroviral intervention studies
Reports of intervention studies were eligible for inclusion if they were of studies published in or after 2000 to the present (2007) of any kind of intervention designed to improve antiretroviral adherence in any HIV-positive person living in the USA. We selected the year 2000 to accommodate the time it likely took for findings from adherence descriptive studies to make their way into adherence intervention studies. We included intervention studies conducted with both women and men as too few adherence intervention studies have targeted women only. We included all designs, including randomized controlled trials, non-randomized studies, and within-subject studies with preÁpost tests. We excluded reports of pilot studies if a later report testing the same intervention in a larger sample was available so that each intervention would be counted only once.
We extracted and tabulated information from each report on the nature of the intervention, the adherence problem targeted, the persons targeted for the intervention, and the intervention outcomes desired. Table 1 shows the results of this work.
Report quality and procedural validity
All reports were reviewed by the first two authors, and all extractions, tabulations, and computations of findings were checked by at least two members of the research team, or discussed until consensus was reached in meetings of the entire research team. No reports of qualitative studies that met selection criteria were excluded for reasons of quality per se as any methodological shortcomings they showed did not invalidate their findings (Sandelowski & Barroso, 2007) . Entire reports of quantitative observational studies that met selection criteria, or specific findings in these reports, were excluded only if it was not possible (even with attempts to contact authors) to calculate effect sizes. No reports of intervention studies that met selection criteria were excluded as our goal was not to summarize their findings, but rather the problems and persons targeted for intervention and the interventions tested.
Results

Factors influencing adherence in descriptive studies
The categories of factors most prominent (i.e. appearing in the largest number of different reports) in favoring adherence were: sociocultural factors (14 reports); relationship with healthcare provider (10 reports); attitudes toward and beliefs about HIV infection and antiretroviral therapy (nine reports); and, medication regimen and motivation/inclination to act (eight reports each). The factors favoring adherence appearing in the largest number of different reports across categories were: having a supportive family and having a supportive provider (six reports each), and believing in the effectiveness and safety of antiretroviral therapy (five reports).
The categories of factors most prominent in favoring non-adherence were: medication regimen (14 reports); sociocultural factors, and attitudes toward and beliefs about HIV infection and antiretroviral therapy (12 reports each), and substance abuse (including drug and alcohol abuse, 11 reports). In addition to the 11 reports comprising the substance abuse category, the most prominent factors across categories favoring non-adherence were: having side effects (13 reports); not wanting others to know HIV status (seven reports); and, uncertainty about the effectiveness and safety of antiretroviral medications and having no symptoms from HIV (six reports each).
Factors targeted in the intervention studies
The primary focus of the intervention reports Á to improve adherence to antiretroviral therapy Á was operationalized in different ways (e.g. adherence to dose or schedule, as measured by number or percentage of missed pills, self-report, pill counts, or Medication Event Monitoring System caps). Of the 47 reports, 23 featured outcome measures in addition to adherence, such as self-efficacy, social support, and a range of mental health indicators.
As shown in Table 1 , the only persons targeted for intervention were HIV-positive persons themselves. Among HIV-positive persons, the primary targets were those with ''poor'' adherence (11 reports) and having a substance abuse problem (10 reports). In nine reports, no specific population target was identified other than being HIV-positive. Women were the sole targets in seven reports (including one report featuring women with substance abuse). Of the 40 remaining reports of studies with both men and women participants, in only five was sex difference addressed in relation to outcomes; in none of these were sex differences found.
Also as shown in Table 1 , 20 of the 47 intervention reports target one specific problem favoring nonadherence, such as forgetting to take medications, depression, substance abuse, risky behaviors, or low health literacy. The problem most targeted in these studies was substance abuse (seven reports, excluding two reports that target persons with substance abuse but do not explicitly present substance abuse as an adherence problem). In contrast, the remaining 27 were the most prevalent interventions, used to address both single problems favoring non-adherence (e.g. substance abuse) and multiple problems favoring non-adherence (e.g. lack of knowledge, forgetting, low self-efficacy).
As shown in Table 2 , the most prevalent problem-intervention combination was the no specific 
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Discussion
Extent to which intervention studies targeted factors found to influence adherence Substance abuse was prominent as a barrier to adherence in descriptive studies and as a target of intervention in intervention studies. Family and provider support was prominent as a facilitator of adherence in descriptive studies, while social support was an explicit intervention component in 12 of the intervention studies and an outcome variable in one additional study. Social support was an implicit component in all of the interventions as any cognitive-behavioral or psycho-educational intervention constitutes a kind of social support.
Side effects were the most prominent factor found to impede adherence, yet interventions to target them were less discernible in the intervention reports. However, the reduction/elimination of side effects may be more amenable to pharmacological than to cognitive-behavioral or psycho-educational interventions directed toward managing side effects. Despite the prominence of the social environment in facilitating or impeding adherence in the descriptive studies, interventions were directed solely toward HIV-positive persons, not, for example, the healthcare system or societal norms. Intervention components were largely in the cognitive domain, even when directed toward non-cognitive elements as, for example, when an educational, not a social, intervention was directed at teaching HIV-positive persons how to mobilize social support.
Researchers have argued that the overly individualistic and rationalist orientation to antiretroviral adherence cannot adequately address the ''hybrid medico-experiential ways of knowing'' (Mykhalovskiy, 2008, p. 138) of HIV-positive persons; the daily ''health work' ' (Bresalier et al., 2002) of which antiretroviral adherence is only a part; the varieties of strategic non-adherence that paradoxically permit overall adherence (Broyles, Colbert, & Erlen, 2005) ; and, the episodic, dose-by-dose nature of medicine taking (Ryan & Wagner, 2003; Wilson, Hutchinson, & Holzemer, 2002b) . Both descriptive and intervention studies leaned toward the cognitive, but that lean may not capture the ongoing work of medicine taking and the larger sociocultural arena in which this work is embedded.
Targeting, tailoring, and fidelity in antiretroviral intervention studies
Our review raises questions regarding the nature of the interventions themselves. Multiple-component interventions were typically presented in reports as especially suitable for addressing the many factors operating against antiretroviral adherence under the apparent assumption that complexity of problem must be matched to complexity of solution: that a shotgun approach to intervention (i.e. involving multiple components, in addition to multiple delivery channels and/or types of providers) will actually hit the one or more problems in play for any one person receiving the intervention at any given time. In 27 of the 47 intervention reports, either no specific problem or an array of problems influencing adherence were addressed. Interventions targeting many problems at once are as non-specific as the ones targeting no problem at all.
When authors described their interventions as tailored, they were most often actually referring to targeting the problems identified by individual participants as impeding their adherence (e.g. forgetting, lack of self-efficacy) with that component of the intervention that was to be mobilized whenever that problem was identified (e.g. memory prompting, skill-building). In some cases, they were referring to an intervention tailored to a particular medication regimen, not a problem or person per se. Targeting and tailoring were further indistinct when researchers described their interventions as intending to meet the special needs of entire social groups, such as women, Latinos, or substance abusers. Researchers were here invoking what Epstein (2007, chap. 7) referred to as ''niche standardization,'' whereby both the universalism of assuming that all HIV-positive people are the same, and the individualism of assuming that HIVpositive persons share no common ground with each other, are avoided. Tailoring in the intervention studies reviewed involved interventions delivered to individuals seem to have one primary group membership. At issue is which niches are the least likely to minimize differences essential to enhancing antiretroviral adherence.
The essential incompatibility between intervention tailoring and fidelity (a demonstration that an intervention was delivered as planned) complicates the implementation of tailored interventions. In most cases of tailoring, interventions were customized in a scripted way: for example, if the person expressed a knowledge deficit, the intervention protocol dictated what the interventionist was to do or say to reduce it. Unclear was how far tailoring could go before intervention fidelity was undermined. Intervention fidelity was addressed in 17 of the 27 reports of tailored interventions, but in none of them was the incongruity addressed between the tailoring of interventions and the standardization of interventions required to optimize intervention fidelity.
This raises the questions of how tailored an intervention can be before intervention fidelity is impossible to achieve and researchers can no longer claim they tested any one intervention at all, and whether any multiple-component intervention can be tested as a single experimental condition. Although, tailored interventions have been found to be generally superior to control conditions (Richards et al., 2007 ), yet to be sufficiently differentiated in intervention research is whether it was the content, function, or form of the intervention that was standardized or, conversely, altered to fit (Campbell et al., 2000; Castro, Barrera, & Martinez, 2004; Hawe, Shiell, & Riley, 2004 ) some individual, social group, or situation. In tailored intervention studies, outcomes would need to be differentiated by the problem identified and the intervention component implemented in response to that problem.
In conclusion, our review suggests some congruence between factors targeted in antiretroviral adherence intervention studies and those identified in descriptive studies as influencing adherence. Lack of congruence may be due to the complex nature of the adherence problem, individualistic and rationalist orientation toward intervention, or simply the way interventions were presented. Our review also raises questions about the relationships among intervention tailoring, targeting, and fidelity and, in the case of antiretroviral adherence interventions in particular, about how interventions are best structured to capture the ongoing work of adherence and variations in participants, social environment, and type of medication regimen, and to maximize the ability to draw credible conclusions about the effectiveness of interventions for achieving desirable adherence rates.
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